Search research articles
Contact Us
Filters
Showing results (371-380 of 397) with videos related to
Page
of 40
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
January 6, 2022
Pembrolizumab in Patients With Microsatellite Instability-High Advanced Endometrial Cancer: Results From the KEYNOTE-158 Study
David M O'Malley, Giovanni Mendonca Bariani, Philippe A Cassier, et al.
European Journal of Medical Genetics
|
June 22, 2018
Detection of fetal subchromosomal aberration with cell-free DNA screening led to diagnosis of parental translocation: Review of 11344 consecutive cases in a university hospital
Ye-Qing Qian, Xiao-Qing Wang, Min Chen, et al.
Gynecologic Oncology
|
January 23, 2025
Pembrolizumab in microsatellite instability-high/mismatch repair deficient (MSI-H/dMMR) and non-MSI-H/non-dMMR advanced endometrial cancer: Phase 2 KEYNOTE-158 study results
David M O'Malley, Giovani M Bariani, Philippe A Cassier, et al.
Human Genomics
|
July 15, 2024
Post-implantation analysis of genomic variations in the progeny from developing fetus to birth
Yingming Zheng, Chuanping Lin, Wen-Jing Wang, et al.
The Journal of Clinical Endocrinology and Metabolism
|
March 11, 2014
High maternal serum estradiol environment in the first trimester is associated with the increased risk of small-for-gestational-age birth
Xiao-Ling Hu, Chun Feng, Xian-Hua Lin, et al.
Gynecologic Oncology
|
May 8, 2024
Lenvatinib plus pembrolizumab for patients with previously treated advanced ovarian cancer: Results from the phase 2 multicohort LEAP-005 study
Antonio González-Martín, Hyun Cheol Chung, Esma Saada-Bouzid, et al.
Planta Medica
|
July 13, 2017
Bioactive Triterpenoids from the Leaves and Twigs of Lithocarpus litseifolius and L. corneus
Yuan-Bin Cheng, Fan-Jin Liu, Chih-Hsin Wang, et al.
Gynecologic Oncology
|
April 1, 2022
Efficacy and safety of pembrolizumab for patients with previously treated advanced vulvar squamous cell carcinoma: Results from the phase 2 KEYNOTE-158 study
Ronnie Shapira-Frommer, Linda Mileshkin, Ludmila Manzyuk, et al.
Molecular Cytogenetics
|
February 10, 2018
A feasible diagnostic approach for the translocation carrier from the indication of products of conception
Ye-Qing Qian, Xiao-Ying Fu, Xiao-Qing Wang, et al.
Clinical Colorectal Cancer
|
February 28, 2026
Lenvatinib Plus Pembrolizumab for Patients With Previously Treated Advanced Colorectal Cancer: Results From the Phase II LEAP-005 Study
Iván Victoria Ruiz, Nataliya V Uboha, Rahima Jamal, et al.
Page
of 40
Search research articles
Search
Showing results (371-380 of 397) with videos related to
Sort By:
Page
of 40
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
January 6, 2022
Pembrolizumab in Patients With Microsatellite Instability-High Advanced Endometrial Cancer: Results From the KEYNOTE-158 Study
David M O'Malley, Giovanni Mendonca Bariani, Philippe A Cassier, et al.
European Journal of Medical Genetics
|
June 22, 2018
Detection of fetal subchromosomal aberration with cell-free DNA screening led to diagnosis of parental translocation: Review of 11344 consecutive cases in a university hospital
Ye-Qing Qian, Xiao-Qing Wang, Min Chen, et al.
Gynecologic Oncology
|
January 23, 2025
Pembrolizumab in microsatellite instability-high/mismatch repair deficient (MSI-H/dMMR) and non-MSI-H/non-dMMR advanced endometrial cancer: Phase 2 KEYNOTE-158 study results
David M O'Malley, Giovani M Bariani, Philippe A Cassier, et al.
Human Genomics
|
July 15, 2024
Post-implantation analysis of genomic variations in the progeny from developing fetus to birth
Yingming Zheng, Chuanping Lin, Wen-Jing Wang, et al.
The Journal of Clinical Endocrinology and Metabolism
|
March 11, 2014
High maternal serum estradiol environment in the first trimester is associated with the increased risk of small-for-gestational-age birth
Xiao-Ling Hu, Chun Feng, Xian-Hua Lin, et al.
Gynecologic Oncology
|
May 8, 2024
Lenvatinib plus pembrolizumab for patients with previously treated advanced ovarian cancer: Results from the phase 2 multicohort LEAP-005 study
Antonio González-Martín, Hyun Cheol Chung, Esma Saada-Bouzid, et al.
Planta Medica
|
July 13, 2017
Bioactive Triterpenoids from the Leaves and Twigs of Lithocarpus litseifolius and L. corneus
Yuan-Bin Cheng, Fan-Jin Liu, Chih-Hsin Wang, et al.
Gynecologic Oncology
|
April 1, 2022
Efficacy and safety of pembrolizumab for patients with previously treated advanced vulvar squamous cell carcinoma: Results from the phase 2 KEYNOTE-158 study
Ronnie Shapira-Frommer, Linda Mileshkin, Ludmila Manzyuk, et al.
Molecular Cytogenetics
|
February 10, 2018
A feasible diagnostic approach for the translocation carrier from the indication of products of conception
Ye-Qing Qian, Xiao-Ying Fu, Xiao-Qing Wang, et al.
Clinical Colorectal Cancer
|
February 28, 2026
Lenvatinib Plus Pembrolizumab for Patients With Previously Treated Advanced Colorectal Cancer: Results From the Phase II LEAP-005 Study
Iván Victoria Ruiz, Nataliya V Uboha, Rahima Jamal, et al.
Page
of 40